Cart
sales@molnova.com
(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
CAS No. 129133-27-3
(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)( ——— )
Catalog No. M40115 CAS No. 129133-27-3
(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
-
NoteResearch use only, not for human use.
-
Brief Description(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
-
Description(D-Phe12,Nle21·38)-CRF (12-41) (human, rat)
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number129133-27-3
-
Formula Weight3539.18
-
Molecular FormulaC158H265N49O43
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
cAMP-Dependent Prote...
PKI(5-22)amide is the active inhibitory fragment of the inhibitor of the cyclic AMP-dependent protein kinase (PKA). PKI(5-22)amide inhibits PKA activation, but fails to attenuate homologous desensitization of CRF1 receptors.
-
TG2-IN-3h
TG2-IN-3h is a transglutaminase (TGase) inhibitor used in the study of neurological and immune system disorders.
-
Glembatumumab vedoti...
Glembatumumab vedotin (CDX-011) is an antibody-drug conjugate with potent anticancer effects, utilized in the study of triple negative breast cancer (TNBC).
